Skip to main content
. 2017 Oct 25;106(6):1463–1470. doi: 10.3945/ajcn.117.162263

TABLE 1.

Participant characteristics1

Overall (n = 128) Elevated (n = 33) Nonelevated (n = 95) P
Age, y 71.3 ± 5.12 72.5 ± 4.6 71.0 ± 5.2 0.15
Sex (F/M), n 84/44 19/14 65/30 0.50
 F/M, % 66/34 59/41 68/32
BMI, kg/m2 28.9 ± 4.8 28.4 ± 4.2 29.0 ± 5.0 0.51
Diagnosed diabetes, n (%) 16 (13) 6 (18) 10 (11) 0.38
 Taking oral diabetes medications 15 (12) 5 (15) 10 (11) 0.66
Education, y 16.5 ± 2.6 16.4 ± 3.1 16.6 ± 2.4 0.78
Dietary intake3
 Energy, kcal 1590 ± 670 1700 ± 760 1550 ± 640 0.24
 Fat, g 66 ± 31 68 ± 31 65 ± 31 0.53
 Protein, g 65 ± 32 69 ± 29 64 ± 33 0.51
Dietary glycemic measures3
 Carbohydrate, g 184 ± 85 208 ± 112 176 ± 72 0.05
 Sugar, g 86 ± 49 102 ± 64 81 ± 42 0.03
 Glycemic load 96 ± 47 106 ± 58 92 ± 43 0.11
 HGLDiet pattern 0.1 ± 1.0 0.5 ± 1.1 −0.1 ± 1.0 0.01
Cognition scores
 MMSE 29 ± 1 29 ± 1 29 ± 2 0.94
 WAIS-R Digit Symbol 51 ± 10 49 ± 10 51 ± 10 0.18
 Trail Making Test A 29 ± 10 31 ± 10 29 ± 10 0.30
 Trail Making Test B 79 ± 38 78 ± 25 79 ± 41 0.88
 Category Fluency 39 ± 8 38 ± 8 39 ± 8 0.54
 Block Design 37 ± 11 36 ± 10 37 ± 11 0.41
 Stroop 219 ± 32 216 ± 32 220 ± 32 0.45
 SRT–free total 31 ± 5 29 ± 5 31 ± 5 0.05
SUVR4
 Global 1.1 ± 0.2 1.3 ± 0.2 1.0 ± 0.1 <0.001
 Anterior cingulate gyrus 1.2 ± 0.2 1.4 ± 0.2 1.1 ± 0.1 <0.001
 Inferior medial frontal gyrus 1.0 ± 0.2 1.2 ± 0.2 0.9 ± 0.1 <0.001
 Lateral temporal lobe 1.1 ± 0.2 1.3 ± 0.2 1.0 ± 0.1 <0.001
 Posterior cingulate gyrus 1.1 ± 0.2 1.2 ± 0.2 1.0 ± 0.1 <0.001
 Precuneus 1.1 ± 0.2 1.4 ± 0.2 1.0 ± 0.1 <0.001
 Superior parietal lobule 1.0 ± 0.2 1.2 ± 0.2 1.0 ± 0.1 <0.001
1

Group differences were assessed by ANCOVA adjusted for age and sex. Significance was set at P ≤ 0.05. HGLDiet, high-glycemic-load diet; MMSE, Mini-Mental State Examination; SRT, Selective Reminding Test; Stroop, Stroop Color-Word Interference Test; SUVR, standard uptake value ratio; WAIS-R, Wechsler Adult Intelligence Scale–Revised.

2

Mean ± SD (all such values).

3

Derived by using a food-frequency questionnaire.

4

Derived by using florbetapir F-18 positron emission tomography imaging.